D-0127-2024 Class III Terminated
FDA drug recall D-0127-2024 was initiated by Teva Pharmaceuticals USA, Inc on November 10, 2023 and is designated Class III. Reason for recall: OOS for viscosity The recall status is terminated (terminated June 3, 2024).
Recall Details
- Product Type
- Drugs
- Report Date
- December 6, 2023
- Initiation Date
- November 10, 2023
- Termination Date
- June 3, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
Product Description
Testosterone Gel, 1.62% CIII (Alcohol 80% v/v), packaged in 30 unit-dose packets per carton, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0591-2926-30
Reason for Recall
OOS for viscosity
Distribution Pattern
USA nationwide
Code Information
Lot #: 100029472, Exp. 2/29/2024